Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1259)
ARVINAS, INC. (ARVN)
Saik Andrew — Chief Financial Officer
Shares
5,696
Price
$8.16
Total Value
$46.47K
Shares Held After
187,432
% of Holdings
2.9%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
30,774
Price
$21.13
Total Value
$650.25K
Shares Held After
1,106,036
% of Holdings
2.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
39,131
Price
$21.13
Total Value
$826.84K
Shares Held After
1,510,157
% of Holdings
2.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
77,855
Price
$21.13
Total Value
$1.65M
Shares Held After
4,805,639
% of Holdings
1.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
173
Price
$99.98
Total Value
$17.30K
Shares Held After
613,589
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,235
Price
$99.98
Total Value
$123.48K
Shares Held After
3,461,521
% of Holdings
0.0%
Aditxt, Inc. (ADTX)
Takeover Time 2026 LLC — 10% Owner
Shares
3,420,439
Price
$0.02
Total Value
$68.41K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
320
Price
$275.10
Total Value
$88.03K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,290
Price
$274.12
Total Value
$353.61K
Shares Held After
320
% of Holdings
80.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,800
Price
$273.30
Total Value
$491.95K
Shares Held After
1,610
% of Holdings
52.8%
BeOne Medicines Ltd. (ONC)
Wang Lai — President, Global Head of R&D
Shares
1,068
Price
$276.74
Total Value
$295.55K
Shares Held After
0
% of Holdings
100.0%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
117,592
Price
$54.47
Total Value
$6.41M
Shares Held After
559,399
% of Holdings
17.4%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
32,408
Price
$54.11
Total Value
$1.75M
Shares Held After
676,991
% of Holdings
4.6%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
1,292
Price
$276.26
Total Value
$356.93K
Shares Held After
0
% of Holdings
100.0%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
1,450
Price
$18.00
Total Value
$26.10K
Shares Held After
51,776
% of Holdings
2.7%
Protagonist Therapeutics, Inc (PTGX)
Waddill William D. — Director
Shares
9,000
Price
$117.94
Total Value
$1.06M
Shares Held After
7,825
% of Holdings
53.5%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
9,810
Price
$12.00
Total Value
$117.72K
Shares Held After
8,617
% of Holdings
53.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Champoux Jennifer — Chief Operating Officer
Shares
2,175
Price
$20.00
Total Value
$43.50K
Shares Held After
62,371
% of Holdings
3.4%
Monte Rosa Therapeutics, Inc. (GLUE)
Townson Sharon — Chief Scientific Officer
Shares
3,000
Price
$20.00
Total Value
$60.00K
Shares Held After
67,845
% of Holdings
4.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
11,845
Price
$20.22
Total Value
$239.52K
Shares Held After
59,992
% of Holdings
16.5%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
7,557
Price
$3.14
Total Value
$23.73K
Shares Held After
0
% of Holdings
100.0%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
2,500
Price
$10.00
Total Value
$25.00K
Shares Held After
130,180
% of Holdings
1.9%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
15,000
Price
$9.47
Total Value
$142.05K
Shares Held After
132,680
% of Holdings
10.2%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
4,117
Price
$0.90
Total Value
$3.70K
Shares Held After
1,724,349
% of Holdings
0.2%
Quantum-Si Inc (QSI)
Vieceli John S. — Chief Product Officer
Shares
15,112
Price
$0.90
Total Value
$13.59K
Shares Held After
1,140,434
% of Holdings
1.3%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
11,311
Price
$0.90
Total Value
$10.17K
Shares Held After
3,669,802
% of Holdings
0.3%
Quantum-Si Inc (QSI)
LaPointe Christian — GC & Corp. Secretary
Shares
7,794
Price
$0.90
Total Value
$7.01K
Shares Held After
1,182,429
% of Holdings
0.7%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
75,000
Price
$0.04
Total Value
$3.38K
Shares Held After
93,769,319
% of Holdings
0.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
17,426
Price
$14.25
Total Value
$248.32K
Shares Held After
176,649
% of Holdings
9.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
101,579
Price
$14.25
Total Value
$1.45M
Shares Held After
834,673
% of Holdings
10.8%
Nuvation Bio Inc. (NUVB)
Markel Stacy — CHIEF PEOPLE OFFICER
Shares
125,000
Price
$6.03
Total Value
$753.19K
Shares Held After
32,591
% of Holdings
79.3%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
425
Price
$25.91
Total Value
$11.01K
Shares Held After
17,413
% of Holdings
2.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,969
Price
$24.84
Total Value
$48.91K
Shares Held After
16,988
% of Holdings
11.6%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
6,836
Price
$24.12
Total Value
$164.88K
Shares Held After
15,019
% of Holdings
45.5%
Nuvation Bio Inc. (NUVB)
Wentworth Kerry — CHIEF REGULATORY OFFICER
Shares
63,000
Price
$6.02
Total Value
$379.19K
Shares Held After
53,000
% of Holdings
54.3%
Nuvation Bio Inc. (NUVB)
Sauvage Philippe — Chief Financial Officer
Shares
47,668
Price
$6.01
Total Value
$286.37K
Shares Held After
12,673
% of Holdings
79.0%
BioCardia, Inc. (BCDA)
STERTZER SIMON H — Director
Shares
39,000
Price
$1.00
Total Value
$39.00K
Shares Held After
166,338
% of Holdings
23.4%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
2,196
Price
$68.57
Total Value
$150.58K
Shares Held After
8,383
% of Holdings
20.8%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
1,697
Price
$28.06
Total Value
$47.62K
Shares Held After
897,240
% of Holdings
0.2%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
14,067
Price
$27.69
Total Value
$389.48K
Shares Held After
898,937
% of Holdings
1.5%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
2,196
Price
$68.57
Total Value
$150.58K
Shares Held After
9,259
% of Holdings
19.2%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
2,277
Price
$3.20
Total Value
$7.29K
Shares Held After
117,145
% of Holdings
1.9%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
88
Price
$38.43
Total Value
$3.38K
Shares Held After
198,244
% of Holdings
0.0%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
18,412
Price
$37.93
Total Value
$698.39K
Shares Held After
198,332
% of Holdings
8.5%
Immuneering Corp (IMRX)
Zeskind Benjamin J. — Director
Shares
2,400
Price
$4.56
Total Value
$10.95K
Shares Held After
2,315,252
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
1,657
Price
$21.47
Total Value
$35.58K
Shares Held After
3,848,256
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
71,629
Price
$21.04
Total Value
$1.51M
Shares Held After
3,849,913
% of Holdings
1.8%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
23,865
Price
$26.05
Total Value
$621.67K
Shares Held After
319,079
% of Holdings
7.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,227
Price
$546.00
Total Value
$669.94K
Shares Held After
40,513
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,407
Price
$545.19
Total Value
$1.86M
Shares Held After
41,740
% of Holdings
7.5%
Showing 51–100 of 1259 transactions (page 2 of 26)